Jane Street’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443K Buy
+52,900
New +$556K ﹤0.01% 8347
2024
Q3
Sell
-20,200
Closed -$236K 10280
2024
Q2
$236K Buy
+20,200
New +$314K ﹤0.01% 8158
2023
Q3
Sell
-15,900
Closed -$318K 9257
2023
Q2
$318K Buy
+15,900
New +$306K ﹤0.01% 7030
2023
Q1
Sell
-30,200
Closed -$685K 9774
2022
Q4
$685K Buy
30,200
+3,200
+12% +$72.3K ﹤0.01% 5607
2022
Q3
$714K Buy
27,000
+800
+3% +$23.7K ﹤0.01% 6033
2022
Q2
$647K Buy
26,200
+19,500
+291% +$487K ﹤0.01% 6274
2022
Q1
$222K Buy
6,700
+400
+6% +$11.1K ﹤0.01% 8889
2021
Q4
$206K Sell
6,300
-236,100
-97% -$8.04M ﹤0.01% 8780
2021
Q3
$10.2M Buy
242,400
+220,900
+1,027% +$7.95M ﹤0.01% 1784
2021
Q2
$835K Buy
21,500
+14,800
+221% +$529K ﹤0.01% 6220
2021
Q1
$229K Buy
+6,700
New +$286K ﹤0.01% 8090

Other funds holding RGNX